- Clinical characteristics and nursing diagnoses of pediatric patients hospitalized with inflammatory bowel disease: a single-center retrospective study in South Korea
-
Jo SY, Bang KS
- KMID: 2544698
- Child Health Nurs Res.
- 2023 Jul;29(3):218-228.
- doi: 10.4094/chnr.2023.29.3.218
Purpose: This study aimed to identify clinical characteristics of South Korean pediatric inflammatory bowel disease (IBD) in a children's hospital over the past 5 years, with a specific focus on... -
- CITED
-
- Close
- SHARE
-
- Close
- Network pharmacology and molecular docking reveal the mechanism of Qinghua Xiaoyong Formula in Crohn’s disease
-
Fang C, Pei Y, Peng Y, Lu H, Qu Y, Luo C, Lu Y, Yang W
- KMID: 2544138
- Korean J Physiol Pharmacol.
- 2023 Jul;27(4):365-374.
- doi: 10.4196/kjpp.2023.27.4.365
Crohn's disease (CD) is a chronic inflammatory illness of the digestive system with unknown etiology, and its incidence is increasing worldwide. However, there are currently no effective treatments or medications... -
- CITED
-
- Close
- SHARE
-
- Close
- Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence
-
Ukashi O, Soffer S, Klang E, Eliakim R, Ben-Horin S, Kopylov U
- KMID: 2544894
- Gut Liver.
- 2023 Jul;17(4):516-528.
- doi: 10.5009/gnl220507
Video capsule endoscopy (VCE) of the small-bowel has been proven to accurately diagnose small-bowel inflammation and to predict future clinical flares among patients with Crohn’s disease (CD). In 2017, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Fecal Fungal Microbiota (Mycobiome) Study as a Potential Tool for Precision Medicine in Inflammatory Bowel Disease
-
Balderramo DC, Romagnoli PA, Granlund AvB, Catalan-Serra I
- KMID: 2544893
- Gut Liver.
- 2023 Jul;17(4):505-515.
- doi: 10.5009/gnl220537
There is growing evidence of the role of fungal microbiota in the pathogenesis of inflammatory bowel disease (IBD). Fungi can exert direct pro-inflammatory effects or modify the bacterial composition via... -
- CITED
-
- Close
- SHARE
-
- Close
- Submucosal fat accumulation in Crohn’s disease: evaluation with sonography
-
Ripollés T, Martínez-Pérez MJ, Paredes JM, Vizuete J, Martin G, Navarro L
- KMID: 2544761
- Intest Res.
- 2023 Jul;21(3):385-391.
- doi: 10.5217/ir.2022.00030
Background/Aims: The study objective is to investigate the ultrasound features that allow suspecting the presence of submucosal fat deposition, called the fat halo sign (FHS), in the intestinal wall of... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study
-
Kim K, Choi K, Hwang SW, Im JP, Ye BD, Kim JS, Park KJ, Yang SK, Koh SJ, Park SH, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
- KMID: 2544900
- Gut Liver.
- 2023 Jul;17(4):581-590.
- doi: 10.5009/gnl220220
Background/Aims: Owing to the low prevalence of small-bowel adenocarcinoma (SBA), data on the impact of Crohn’s disease (CD) on the survival of patients with SBA are lacking. Therefore, we investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
-
Giri S, Agrawal D, Afzalpurkar S, Kasturi S, Gopan A, Sundaram S, Kale A
- KMID: 2544762
- Intest Res.
- 2023 Jul;21(3):392-405.
- doi: 10.5217/ir.2022.00094
Background/Aims: The data on the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in patients with inflammatory bowel disease (IBD) are conflicting. The present systematic review... -
- CITED
-
- Close
- SHARE
-
- Close
- Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
-
Singh A, Gupta YK, Dhaliwal AS, Kahlon BK, Bansal V, Mahajan R, Mehta V, Singh D, Kaur R, Bansal N, Midha V, Sood A
- KMID: 2544760
- Intest Res.
- 2023 Jul;21(3):375-384.
- doi: 10.5217/ir.2022.00037
Background/Aims: The inflammatory bowel disease (IBD)-disk is a validated, visual, 10-item, self-administered questionnaire used to evaluate IBD-related disability. The present study aimed to evaluate IBD-disk in assessment of IBD daily... -
- CITED
-
- Close
- SHARE
-
- Close
- Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn’s Disease Comparing, between CT-P13 and Originator Infliximab
-
Park J, Cheon JH, Lee KM, Kim YH, Ye BD, Eun CS, Kim SH, Lee SH, Lee JH, Schreiber S
- KMID: 2542344
- Gut Liver.
- 2023 May;17(3):430-440.
- doi: 10.5009/gnl220005
Background/Aims: The clinical efficacy and safety of CT-P13 are comparable to originator infliximab for Crohn’s disease in CT-P13 3.4 study (NCT02096861). We performed a multivariate logistic analysis to demonstrate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Exclusive Enteral Nutrition for the Treatment of Pediatric Crohn’s Disease: The Patient Perspective
-
Brown SC, Wall CL, Gearry RB, Day AS
- KMID: 2542401
- Pediatr Gastroenterol Hepatol Nutr.
- 2023 May;26(3):165-172.
- doi: 10.5223/pghn.2023.26.3.165
Crohn’s disease (CD) is a chronic, incurable and relapsing disease involving any part of the gastrointestinal tract and exclusive enteral nutrition (EEN) is first-line therapy. Few studies have examined the... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Case Reports of Newly Diagnosed Crohn’s Disease after COVID-19 in Pediatric Patients
-
Kim K, Kim Sy, Kim YE, Kwon KW, Han EM, Kim A
- KMID: 2541778
- Korean J Gastroenterol.
- 2023 Apr;81(4):163-167.
- doi: 10.4166/kjg.2022.144
Since the coronavirus disease 2019 (COVID-19) outbreak caused by the severe acute respiratory syndrome-coronavirus-2 virus (SARS-CoV-2), various complications have been reported. Although most COVID-19 cases exhibited flu-like symptoms, COVID-19 may... -
- CITED
-
- Close
- SHARE
-
- Close
- Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
-
Jun YK, Yoon H, Koh SJ, Kim AH, Kim KW, Park JW, Lee HJ, Kang HW, Im JP, Park YS, Kim JS, on behalf of Seoul National University Inflammatory Bowel Disease Research Network (SIRN)
- KMID: 2541897
- Intest Res.
- 2023 Apr;21(2):244-251.
- doi: 10.5217/ir.2022.00057
Background/Aims: Patients with inflammatory bowel disease (IBD) are diagnosed with ankylosing spondylitis (AS) often. However, the disease course of patients with both IBD and AS is not well understood. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical spectrum of elderly-onset inflammatory bowel disease in India
-
Gupta YK, Singh A, Narang V, Midha V, Mahajan R, Mehta V, Singh D, Bansal N, Durairaj MVB, Dutta AK, Sood A
- KMID: 2541894
- Intest Res.
- 2023 Apr;21(2):216-225.
- doi: 10.5217/ir.2021.00177
Background/Aims: Inflammatory bowel disease (IBD) is increasingly being recognized in elderly patients. Data on clinical spectrum of elderly-onset IBD patients is lacking from India. Methods: A cross-sectional retrospective analysis of a... -
- CITED
-
- Close
- SHARE
-
- Close
- Proposal of novel staging system CNM (Crohn’s primary site, nodes, mesentery) to predict postoperative recurrence of Crohn’s disease
-
Rao GV, Pal P, Sekaran A, Rebala P, Tandan M, Reddy DN
- KMID: 2541892
- Intest Res.
- 2023 Apr;21(2):196-204.
- doi: 10.5217/ir.2022.00045
After oncologic resection, histological grading and staging of the tumor give important prognostic information about the future risk of recurrence and hence influence the subsequent management plan. Several studies and... -
- CITED
-
- Close
- SHARE
-
- Close
- Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
-
Sachdeva K, Kumar P, Kante B, Vuyyuru SK, Mohta S, Ranjan MK, Singh MK, Verma M, Makharia G, Kedia S, Ahuja V
- KMID: 2541895
- Intest Res.
- 2023 Apr;21(2):226-234.
- doi: 10.5217/ir.2022.00010
Background/Aims: Intestinal tuberculosis (ITB) and Crohn’s disease (CD) frequently present with a diagnostic dilemma because of similar presentation. Interferon-gamma release assay (IGRA) has been used in differentiating ITB from CD,... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiologic images of complications of Crohn’s disease
-
Yoon S, Park SH, Kim JS
- KMID: 2539254
- Int J Gastrointest Interv.
- 2023 Jan;12(1):29-36.
- doi: 10.18528/ijgii220003
Crohn’s disease is a chronic inflammatory disease that may occur in the alimentary tract and has various clinical courses. It is characterized by several complications, including bowel strictures, bowel obstruction,... -
- CITED
-
- Close
- SHARE
-
- Close
- Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn’s Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability
-
Tomita T, Fukui H, Morishita D, Maeda A, Makizaki Y, Tanaka Y, Ohno H, Oshima T, Miwa H
- KMID: 2537945
- J Neurogastroenterol Motil.
- 2023 Jan;29(1):102-112.
- doi: 10.5056/jnm22027
Background/Aims Diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms frequently occur in patients with quiescent Crohn’s disease (CD). To investigate the factors underlying IBS-D-like symptoms in patients with quiescent CD, we performed a... -
- CITED
-
- Close
- SHARE
-
- Close
- Inflammatory bowel disease–associated intestinal fibrosis
-
Park JM, Kim J, Lee YJ, Bae SU, Lee HW
- KMID: 2539037
- J Pathol Transl Med.
- 2023 Jan;57(1):60-66.
- doi: 10.4132/jptm.2022.11.02
Fibrosis is characterized by a proliferation of fibroblasts and excessive extracellular matrix following chronic inflammation, and this replacement of organ tissue with fibrotic tissue causes a loss of function. Inflammatory... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease
-
Koh SJ, Hong SN, Park SK, Ye BD, Kim KO, Shin JE, Yoon YS, Lee HS, Jung SH, Choi M, Na SY, Choi CH, Kim JS, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
- KMID: 2539006
- Intest Res.
- 2023 Jan;21(1):43-60.
- doi: 10.5217/ir.2022.00029
Crohn’s disease (CD) is a relapsing and progressive condition characterized by diarrhea, abdominal pain, weight loss, and hematochezia that results in serious complications such as perforations, fistulas, and abscesses. Various... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
-
Oh K, Hong HS, Ham NS, Lee J, Park SH, Yang SK, Yoon H, Kim YS, Choi CH, Ye BD, on behalf of the Korean Association for the Study of Intestinal Diseases
- KMID: 2539012
- Intest Res.
- 2023 Jan;21(1):137-147.
- doi: 10.5217/ir.2021.00173
Background/Aims: We investigated the real-world effectiveness and safety of ustekinumab (UST) as induction treatment for Koreans with Crohn’s disease (CD). Methods: CD patients who started UST were prospectively enrolled from 4... -
- CITED
-
- Close
- SHARE
-
- Close
